2023 annual financial data
Lexaria Bioscience 2023 Net margin
Direct answer
Net margin was -2,946.36%.
Operating income was -6,534,022 USD and net income was -6,664,899 USD.
Operating cash flow was -5,881,237 USD.
Get free Lexaria Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 226,208 USD
- Operating income
- -6,534,022 USD
- Net income
- -6,664,899 USD
- Operating cash flow
- -5,881,237 USD